{"id":"W2095717568","doi":"10.1586/14737167.4.2.135","title":"Economic benefits of pioglitazone for treating patients with Type 2 diabetes","year":2004,"lang":"en","type":"article","venue":"Expert Review of Pharmacoeconomics & Outcomes Research","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"ca_institutions":"Eli Lilly (Canada); University of Toronto","funders":"Eli Lilly Canada; Eli Lilly and Company","keywords":"Pioglitazone; Metformin; Type 2 diabetes; Medicine; Sulfonylurea; Diabetes mellitus; Insulin resistance; Intensive care medicine; Insulin; Internal medicine; Endocrinology","routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003303752,0.0003417927,0.0005990366,0.001315766,0.0003909749,0.001272345,0.0003346516,0.001061067,0.005472886],"category_scores_gemma":[0.01558774,0.0001016381,0.000743649,0.001527444,0.0002796542,0.0006333804,0.0006004829,0.0008197837,0.0002838355],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0014422,"about_ca_system_score_gemma":0.00215467,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.002622918,"about_ca_topic_score_gemma":0.004258595,"domain_scores_codex":[0.9970842,0.001952417,0.00009765042,0.0000491443,0.0007340249,0.0000826164],"domain_scores_gemma":[0.9962103,0.002783303,0.000479102,0.00007295828,0.0002482109,0.0002061146],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"observational","study_design_scores_codex":[0.00444496,0.0004933478,0.01555938,0.001607994,0.001215693,0.000611633,0.0001321947,0.01945729,0.0004789039,0.02393244,0.03173447,0.9003317],"study_design_scores_gemma":[0.006148132,0.006969361,0.1864475,0.0141869,0.01110005,0.008681574,0.002557626,0.0918228,0.002543889,0.1923345,0.4768237,0.0003839756],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"review","genre_gemma":"empirical","genre_scores_codex":[0.186568,0.4243312,0.01642353,0.1295847,0.002175975,0.0005617211,0.001647634,0.0001887917,0.2385185],"genre_scores_gemma":[0.8891997,0.09744329,0.005236096,0.002768789,0.001111559,0.0001615178,0.0003317185,0.00001286014,0.003734529],"genre_candidate":"empirical","genre_consensus":null,"teacher_disagreement_score":0.005472886,"threshold_uncertainty_score":0.0183087,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.03182937887154053,"score_gpt":0.4519257589841406,"score_spread":0.4200963801126001,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}